GLP-1 secreting encapsulated human mesenchymal stem cells for neuroprotection
Main Authors: | Wallrapp Christine, Klinge Petra M, Baltes Steffen, Heile Anna, Brinker Thomas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-12-01
|
Series: | Cerebrospinal Fluid Research |
Similar Items
-
Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells
by: Harmening Kathrin, et al.
Published: (2009-11-01) -
Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis.
by: Jui-Yu Hsieh, et al.
Published: (2013-01-01) -
Glucolipotoxicity and GLP-1 secretion
by: Jung-Hee Hong, et al.
Published: (2021-08-01) -
Polysaccharide Hydrogels Support the Long-Term Viability of Encapsulated Human Mesenchymal Stem Cells and Their Ability to Secrete Immunomodulatory Factors
by: Fahd Hached, et al.
Published: (2017-01-01) -
Encapsulation of factor IX–engineered mesenchymal stem cells
in fibrinogen–alginate microcapsules enhances their viability and
transgene secretion
by: Bahareh Sayyar, et al.
Published: (2012-12-01)